Last updated: 3 months ago
XOMA Royalty Corporation's Key Acquisition Report: Pulmokine, Inc.
Discover XOMA Royalty Corporation's strategic acquisition of Pulmokine, Inc. for $20M, enhancing its portfolio and compliance with SEC regulations through detailed financial disclosures.